1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antibody-drug Conjugate Market Size Growth Rate by Type (2020-2025)
1.3.2 Adcetris
1.3.3 Kadcyla
1.4 Market Segment by Application
1.4.1 Global Antibody-drug Conjugate Market Share by Application (2020-2025)
1.4.2 Breast Cancer
1.4.3 Lymphoma
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody-drug Conjugate Market Size
2.1.1 Global Antibody-drug Conjugate Revenue 2015-2025
2.1.2 Global Antibody-drug Conjugate Sales 2015-2025
2.2 Antibody-drug Conjugate Growth Rate by Regions
2.2.1 Global Antibody-drug Conjugate Sales by Regions 2015-2019
2.2.2 Global Antibody-drug Conjugate Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Antibody-drug Conjugate Sales by Manufacturers
3.1.1 Antibody-drug Conjugate Sales by Manufacturers 2015-2019
3.1.2 Antibody-drug Conjugate Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Antibody-drug Conjugate Revenue by Manufacturers (2015-2019)
3.2.2 Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Antibody-drug Conjugate Market Concentration Ratio (CR5 and HHI)
3.3 Antibody-drug Conjugate Price by Manufacturers
3.4 Key Manufacturers Antibody-drug Conjugate Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antibody-drug Conjugate Market
3.6 Key Manufacturers Antibody-drug Conjugate Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Adcetris Sales and Revenue (2015-2019)
4.1.2 Kadcyla Sales and Revenue (2015-2019)
4.2 Global Antibody-drug Conjugate Sales Market Share by Type
4.3 Global Antibody-drug Conjugate Revenue Market Share by Type
4.4 Antibody-drug Conjugate Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antibody-drug Conjugate Sales by Application
6 United States
6.1 United States Antibody-drug Conjugate Breakdown Data by Company
6.2 United States Antibody-drug Conjugate Breakdown Data by Type
6.3 United States Antibody-drug Conjugate Breakdown Data by Application
7 European Union
7.1 European Union Antibody-drug Conjugate Breakdown Data by Company
7.2 European Union Antibody-drug Conjugate Breakdown Data by Type
7.3 European Union Antibody-drug Conjugate Breakdown Data by Application
8 China
8.1 China Antibody-drug Conjugate Breakdown Data by Company
8.2 China Antibody-drug Conjugate Breakdown Data by Type
8.3 China Antibody-drug Conjugate Breakdown Data by Application
9 Rest of World
9.1 Rest of World Antibody-drug Conjugate Breakdown Data by Company
9.2 Rest of World Antibody-drug Conjugate Breakdown Data by Type
9.3 Rest of World Antibody-drug Conjugate Breakdown Data by Application
9.4 Rest of World Antibody-drug Conjugate Breakdown Data by Countries
9.4.1 Rest of World Antibody-drug Conjugate Sales by Countries
9.4.2 Rest of World Antibody-drug Conjugate Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Agensys
10.1.1 Agensys Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.1.4 Antibody-drug Conjugate Product Introduction
10.1.5 Agensys Recent Development
10.2 Concortis Biotherapeutics
10.2.1 Concortis Biotherapeutics Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.2.4 Antibody-drug Conjugate Product Introduction
10.2.5 Concortis Biotherapeutics Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.3.4 Antibody-drug Conjugate Product Introduction
10.3.5 Sanofi Recent Development
10.4 Celldex Therapeutics
10.4.1 Celldex Therapeutics Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.4.4 Antibody-drug Conjugate Product Introduction
10.4.5 Celldex Therapeutics Recent Development
10.5 Synthon Holding BV
10.5.1 Synthon Holding BV Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Antibody-drug Conjugate
10.5.4 Antibody-drug Conjugate Product Introduction
10.5.5 Synthon Holding BV Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antibody-drug Conjugate Sales Channels
11.2.2 Antibody-drug Conjugate Distributors
11.3 Antibody-drug Conjugate Customers
12 Market Forecast
12.1 Global Antibody-drug Conjugate Sales and Revenue Forecast 2020-2025
12.2 Global Antibody-drug Conjugate Sales Forecast by Type
12.3 Global Antibody-drug Conjugate Sales Forecast by Application
12.4 Antibody-drug Conjugate Forecast by Regions
12.4.1 Global Antibody-drug Conjugate Sales Forecast by Regions 2020-2025
12.4.2 Global Antibody-drug Conjugate Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
